FLEQSUVY

Serial Number 90752265
Registration 6908358
700

Registration Progress

Application Filed
Jun 3, 2021
Under Examination
Apr 26, 2022
Approved for Publication
Mar 1, 2022
Published for Opposition
Mar 1, 2022
Registered
Nov 22, 2022

Trademark Image

FLEQSUVY

Basic Information

Serial Number
90752265
Registration Number
6908358
Filing Date
June 3, 2021
Registration Date
November 22, 2022
Published for Opposition
March 1, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 22, 2022
Registration
Registered
Classes
005

Rights Holder

Azurity Pharmaceuticals, Inc.

03
Address
8 Cabot Road, Suite 2000
Woburn, MA 01801

Ownership History

Azurity Pharmaceuticals, Inc.

Original Applicant
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Owner at Publication
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Original Registrant
03
Woburn, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
1065 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20221122)
Due Date
November 22, 2028
Grace Period Ends
May 22, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Mar 19, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Nov 22, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 22, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 20, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 19, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 22, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 9, 2022 IUAF S USE AMENDMENT FILED Loading...
Sep 22, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 9, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 26, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 1, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 1, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 9, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 26, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 25, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 24, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 12, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 12, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 12, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 7, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 26, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 7, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of spasticity resulting from multiple sclerosis, including relief of flexor spasms, concomitant pain, clonus, and muscular rigidity; pain relief medication
First Use Anywhere: Mar 18, 2022
First Use in Commerce: Mar 18, 2022

Classification

International Classes
005